证券分析师 李勇 执业证书：S0600519040001 010-66573671 liyong@dwzq.com.cn 证券分析师 陈伯铭 执业证书：S0600523020002 chenbm@dwzq.com.cn 证券研究报告·固定收益·固收周报 固收周报 20260301 建议关注"困境反转"相关主题转债标的 2026 年 03 月 01 日 相关研究 《二级资本债周度数据跟踪 （20260224-20260227）》 2026-02-28 《绿色债券周度数据跟踪（20260224- 20260227）》 2026-02-28 东吴证券研究所 1 / 13 请务必阅读正文之后的免责声明部分 [Table_Tag] [Table_Summary] ◼ 前周（0223－0227）海外方面美伊外交谈判停滞，隔夜美以联军 对伊朗发动袭击，近两周受美伊形势升级影响，主要油运指数快 速上升，资本市场方面也在渐次定价事态升级，避险情绪显著上 行，市场短期或转向定价滞胀，利多黄金、美债短端。 ◼ 国内方面上周权益题材、权重有所轮动，但量能较节前有所恢 复，多空分歧显著，转债指数层面"意外"出现同加权、等权正 股指数相 ...

Investment Rating - The report maintains a rating of "Overweight" for the mechanical equipment industry [1] Core Insights - The report highlights investment opportunities in the AIDC and solar power sectors due to electricity shortages in North America, as well as historical opportunities in advanced packaging equipment for semiconductors [1][2][3][4] Summary by Sections Investment Recommendations - Recommended companies include: Northern Huachuang, SANY Heavy Industry, Zhongwei Company, Hengli Hydraulic, CIMC, Tuojing Technology, Haitian International, Bichu Electronics, Jingsheng Mechanical, Jereh, Zhejiang Dingli, Hangcha Group, Xianjin Intelligent, Changchuan Technology, Huace Detection, Anhui Helix, Jingce Electronics, Nuwei Co., Chip Source Micro, Green Harmonics, Haitian Precision, Hangke Technology, Yizhiming, New Lai Materials, and High Measurement Shares [1] Gas Turbine Sector - The report notes that President Trump encourages large companies to build their own power sources, which is expected to boost demand for natural gas power generation equipment. The domestic gas turbine industry is highlighted as having significant investment opportunities, particularly for companies like Jereh, Dongfang Electric, and Yingliu [2] Photovoltaic Equipment - The report emphasizes the growing demand for solar power in both terrestrial and space computing applications, with Tesla planning to expand its solar capacity significantly by 2028. Companies recommended in this sector include Maiwei Shares, Jingsheng Mechanical, High Measurement Shares, and Aotwei [3] Semiconductor Equipment - The report discusses the benefits for domestic equipment manufacturers due to rising tensions between China and Japan, which favor local alternatives. Companies like Changchuan Technology, Chip Source Micro, and Maiwei are highlighted as key players benefiting from this trend [4] PCB Equipment and Liquid Cooling - NVIDIA's strong performance is noted, with significant revenue growth indicating robust demand for computing power. The report suggests investment opportunities in the PCB and liquid cooling supply chains, recommending companies like Dazhu CNC, Chip Source Micro, and Yinguang Technology [5][6] Robotics Industry - The report indicates a recent pullback in the robotics sector but suggests that upcoming events, such as the release of Tesla's V3 robot, could catalyze growth. Companies like Hengli Hydraulic and Sanhua Intelligent are recommended as key players [10] Oil and Gas Equipment - The report identifies the Middle East as a core market for oil services, with companies like Jereh and Nuwei highlighted for their growth potential in this region [43]

证券研究报告·行业跟踪周报·机械设备 机械设备行业跟踪周报 看好北美缺电带来的 AIDC 和太空算力光伏 设备机会&关注半导体先进封装设备历史性 机遇 增持（维持） [Table_Tag] [1.Table_Summary] 推荐组合：北方华创、三一重工、中微公司、恒立液压、中集集团、拓荆科技、海天 国际、柏楚电子、晶盛机电、杰瑞股份、浙江鼎力、杭叉集团、先导智能、长川科技、 华测检测、安徽合力、精测电子、纽威股份、芯源微、绿的谐波、海天精工、杭可科 技、伊之密、新莱应材、高测股份、纽威数控、华中数控。 【燃气轮机】特朗普鼓励大厂自建电源，重申国产燃机产业链投资机会 2026 年 2 月 6 日，CNBC 报道称美国总统特朗普将与亚马逊、谷歌、Meta、微软等大型科技公司 高管在白宫会面，并计划于 3 月 4 日签署相关协议，要求在保障 AIDC 持续发展的同时由企业自 行解决电力供应问题，利好天然气发电设备需求，加快项目落地速度。严重的供需失衡环节，重 申国产燃机产业链投资机会：1）GEV/西门子/三菱重工上游零部件扩产难度大，到 2030 年板块 合计产能约 90GW，仍小于总需求；2）产能不足限制美国链 ...

证券研究报告·固定收益·固收周报 固收周报 20260301 周观：震荡格局延续，政策催化仍待确认 （2026 年第 8 期） [Table_Tag] [Table_Summary] 观点 ◼ 节后利率上行叠加人民币升值，如何看待债市后续的运行态势和新催 化？本周（2026.2.24-2026.2.27），10 年期国债活跃券 250016 收益率 从 2 月 13 日的 1.78%上行 2.2bp 至 2 月 27 日的 1.802%。周度复盘：周 二（2.24），春节假期期间，特朗普此前的关税被判无效，再次推出 15% 的对华关税，较先前有所降低，但债市对此定价有限。随后，2026 年 2 月 LPR 公布，与此前持平，符合市场预期。尾盘央行宣布续作 6000 亿 元 MLF，当月到期量为 3000 亿元，展现对资金面呵护态度。假期后首 日，市场成交清淡，全天 10 年期国债活跃券 250016 收益率上行 0.25bp。 周三（2.25），早盘对于上海楼市政策放松有所预期，利率出现上行。午 后政策落地，包括外环内限购政策放宽、公积金可贷额度提高等，利率 继续上行，全天 10 年期国债活跃券 250016 ...

证券研究报告 AI交易切换：重视国产算力和电力建设 ——每周主题、产业趋势交易复盘和展望 证券分析师：陈刚 执业证书编号：S0600523040001 邮箱：cheng@dwzq.com.cn 研究助理：孔思迈 执业证书编号：S0600124070019 邮箱：kongsm@dwzq.com.cn 2026年3月1日 注：本报告所涉及个股/公司仅代表与产业或交易热点有关联，所引述资讯/数据/观点仅以展示为目的，不构成投资建议，个股层面请参照东吴证券研究所各行业组所推荐标的。 目录 1、本周市场回顾 2、产业趋势交易回顾与展望 3 注：本报告所涉及个股/公司仅代表与产业或交易热点有关联，所引述资讯/数据/观点仅以展示为目的，不构成投资建议，个股层面请参照东吴证券研究所各行业组所推荐标的。 3、风险提示 2 注：本报告所涉及个股/公司仅代表与产业或交易热点有关联，所引述资讯/数据/观点仅以展示为目的，不构成投资建议，个股层面请参照东吴证券研究所各行业组所推荐标的。 1. 本周市场回顾 注：本周交易日为2月24日-27日 （如无特殊说明）后文同 ✓ 本周全A日均成交2.44万亿，环比节前一周放量超3000亿 图：万 ...

[Table_Tag] [Table_Summary] 投资要点 ◼ 具体思路:看好的子行业排序分别为:创新药>科研服务>CXO>中药>医疗器械>药店 等。具体标的思路：从中药基药角度，建议关注佐力药业、方盛制药、盘龙药业等。 从 CXO、上游科研服务角度，建议关注药明康德、皓元医药、奥浦迈、百奥赛图、 百普赛斯、纳微科技等。从 PD1 PLUS 角度，建议关注三生制药、康方生物、信达生 物、泽璟制药等。从 ADC 角度，建议关注映恩生物、科伦博泰、百利天恒等。从小 核酸角度，建议关注前沿生物、福元医药、悦康药业等。从自免角度，建议关注康 诺亚、益方生物-U、一品红等。从创新药龙头角度，建议关注百济神州、恒瑞医药 等。从医疗器械角度，建议关注联影医疗、鱼跃医疗等。从 AI 制药角度，建议关注 晶泰控股、英矽智能等。从 GLP1 角度，建议关注联邦制药、博瑞医药、众生药业 等。 证券研究报告·行业跟踪周报·医药生物 医药生物行业跟踪周报 2026 版基药目录调整在即，利好拟纳入目录 的中药标的 增持（维持） ◼ 风险提示：药品或耗材降价超预期；医保政策风险等；产品销售及研发进度不及预 期。 2026 年 03 ...

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [59]. Core Insights - The automotive parts sector has shown a weekly increase of 1.73%, ranking first among the SW automotive indices, with a year-to-date increase of 6.76% [3][18]. - The robotics sector experienced a slight increase of 0.08% this week, with a year-to-date increase of 2.63%, but underperformed compared to the automotive parts sector [3][30]. - Key developments include a strategic partnership between Zhiyuan Robotics and Minshi Group to accelerate the localization and deployment of robotics technology in Europe [3][41]. Summary by Sections Automotive Parts Sector Weekly Review - The automotive parts sector ranked first in the SW automotive index this week, with a year-to-date performance of +6.76% [3][18]. - The sector's PE (TTM) is at 88.37% historical percentile, and PB (LF) is at 81.92% historical percentile as of February 27, 2026 [3][28]. Robotics Sector Weekly Review - The robotics index increased by 0.08% this week, with a year-to-date performance of +2.63% [3][30]. - The latest PE (TTM) for the robotics sector is at 49.89% historical percentile, and PB (LF) is at 57.01% historical percentile as of February 27, 2026 [40]. Key Stock Tracking - Notable weekly gainers include Xingyuan Zhuomei (+10.64%), Bertley (+7.15%), and Feilong Co. (+7.11%) [3][48]. - Core stocks in the automotive parts sector include Fuyao Glass, Xingyu Co., Minshi Group, and Junsheng Electronics, with specific recommendations based on EPS and PE dimensions [54]. Investment Recommendations - For the automotive parts sector, focus on structural opportunities by selecting product-oriented companies and those entering high-value segments to enhance ASP [54]. - In the robotics sector, look for certainty in opportunities, particularly with the anticipated release of Optimus V3 and the application of domestic manufacturers like Xiaopeng and Yushu [54].

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [59]. Core Insights - The automotive parts sector has shown a weekly increase of 1.73%, ranking first among the SW automotive indices, with a year-to-date increase of 6.76% [3][18]. - The robotics sector experienced a slight increase of 0.08% this week, with a year-to-date increase of 2.63%, but underperformed compared to the automotive parts sector [3][30]. - Key developments include a strategic partnership between Zhiyuan and Minshi Group to accelerate the localization and deployment of robotic technology in Europe, and the launch of a new quadruped robot by Yushu [3][41]. Automotive Parts Sector Summary - The SW automotive parts PE (TTM) is at the historical 88.37% percentile, while the PB (LF) is at 81.92% [3][28]. - The top five gainers in the automotive parts sector this week were: Xingyuan Zhuomei (+10.64%), Berteli (+7.15%), Feilong Co. (+7.11%), Changhua Group (+5.19%), and Yinlun Co. (+4.73%) [3][48]. - The sector's trading volume has shown a slight recovery post the Lunar New Year, but demand remains affected by market conditions [3][25]. Robotics Sector Summary - The latest trading day for the robotics sector shows a PE (TTM) at 1.36 times that of the broader market, with a PB (LF) at 1.84 times [40]. - The sector's trading activity has seen a modest increase due to performances at the Spring Festival Gala, although it remains at historical lows [37][30]. - Significant events include the entry of Zhiyuan into the German market and the unveiling of a humanoid robot by Honor at an upcoming exhibition [41][43]. Investment Recommendations - For the automotive parts sector, focus on structural opportunities by selecting product-oriented companies and those entering high-value segments to enhance ASP, particularly in Europe, North America, and Southeast Asia [3][54]. - In the robotics sector, look for certainty in opportunities, especially with the anticipated release of Optimus V3 and the application developments from companies like Xiaopeng, Yushu, and Zhiyuan [3][54].

证券研究报告·行业跟踪周报·非银金融 非银金融行业跟踪周报 无惧短期调整，继续看好保险基本面改善与 估值提升 增持（维持） [Table_Tag] [Table_Summary] 投资要点 2026 年 03 月 01 日 证券分析师 孙婷 执业证书：S0600524120001 sunt@dwzq.com.cn 证券分析师 罗宇康 执业证书：S0600525090002 luoyk@dwzq.com.cn 行业走势 -9% -6% -3% 0% 3% 6% 9% 12% 15% 18% 21% 24% 2025/3/3 2025/7/1 2025/10/29 2026/2/26 非银金融 沪深300 相关研究 《保险行业总资产突破 41 万亿；券商 再融资持续推进》 2026-02-23 《西南证券拟定增 60 亿元，券商定增 或全面放开》 2026-02-14 东吴证券研究所 1 / 15 请务必阅读正文之后的免责声明部分 ◼ 非银行金融子行业近期表现：最近 4 个交易日（2026 年 02 月 24 日-2026 年 02 月 27 日）非银金融各子版块中仅多元金融行业跑赢沪深 300 指 数。多元金融 ...

证券研究报告·行业跟踪周报·医药生物 医药生物行业跟踪周报 2026 版基药目录调整在即，利好拟纳入目录 的中药标的 增持（维持） [Table_Tag] [Table_Summary] 投资要点 ◼ 具体思路:看好的子行业排序分别为:创新药>科研服务>CXO>中药>医疗器械>药店 等。具体标的思路：从中药基药角度，建议关注佐力药业、方盛制药、盘龙药业等。 从 CXO、上游科研服务角度，建议关注药明康德、皓元医药、奥浦迈、百奥赛图、 百普赛斯、纳微科技等。从 PD1 PLUS 角度，建议关注三生制药、康方生物、信达生 物、泽璟制药等。从 ADC 角度，建议关注映恩生物、科伦博泰、百利天恒等。从小 核酸角度，建议关注前沿生物、福元医药、悦康药业等。从自免角度，建议关注康 诺亚、益方生物-U、一品红等。从创新药龙头角度，建议关注百济神州、恒瑞医药 等。从医疗器械角度，建议关注联影医疗、鱼跃医疗等。从 AI 制药角度，建议关注 晶泰控股、英矽智能等。从 GLP1 角度，建议关注联邦制药、博瑞医药、众生药业 等。 ◼ 风险提示：药品或耗材降价超预期；医保政策风险等；产品销售及研发进度不及预 期。 2026 年 03 ...